Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 262801000036116 | Pegasys-RBV (4 x 180 microgram syringes, 112 x 200 mg tablets), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4113781000168112 | Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | has container type | pack | true | Inferred relationship | Some | ||
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | has container type | composite pack | false | Inferred relationship | Some | ||
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | has TP | Pegasys-RBV | true | Inferred relationship | Some | ||
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | has TPUU | Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe | true | Inferred relationship | Some | 1 | |
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | has component pack | Pegasys 180 microgram/0.5 mL injection, 4 x 0.5 mL syringes | true | Inferred relationship | Some | ||
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | has component pack | Copegus 200 mg tablet, 112 tablets, bottle | true | Inferred relationship | Some | ||
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | Is a | Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (trade product pack) | true | Inferred relationship | Some | ||
| Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) | has TPUU | Copegus 200 mg tablet, 1 tablet | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR